Newsroom
The latest news and updates on Sooma tDCS™, neurostimulation treatment, and what’s happening at Sooma Medical.
Sooma launches system for remote clinician-monitored brain stimulation
Read more
Sooma becomes the first tDCS device manufacturer to receive European MDR certification
Read more
Open-Label Study Highlights Efficacy of Sooma Depression Therapy for MDD Treatment
Read more
Sooma Receives Intention to Grant Patent from EPO for Its Innovative Electrode Placement System, Reinforcing Patent Portfolio
Read more
FDA Breakthrough Device Designation granted to Sooma for Its Innovative At-Home Depression Treatment Device
Read more
New European Regulation reclassifies brain stimulation equipment without an intended medical purpose as class III
Read more
Sooma’s latest study provides the largest dataset to date on the effects of tDCS for treating MDD in real-world clinical practice
Read more
Sooma reaches more than 10,000 patients treated with its tDCS devices
Read more
Sooma starts a collaboration with the Non-Invasive Brain Stimulation Lab at University Medical Center (Göttingen)
Read more
Treating depression shouldn’t be hard
Read more